Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse
- PMID: 2142009
Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse
Abstract
The catabolism of streptokinase (SK) and polyethylene glycol derivatives of SK (PEG-SK) were studied in mice. The clearance and catabolism of SK:plasmin (SK:Pm) and PEG-SK:Pm activator complexes were also investigated. Native 125I-SK cleared rapidly (t1/2 = 15 minutes) from the circulation, with the majority of the ligand accumulating in the liver and gastrointestinal (GI) tract and a substantial fraction also localizing in the kidneys. SK, which was removed from the plasma by the liver, was secreted into bile and then the GI tract. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) demonstrated that 125I-SK recovered from liver and bile was homogeneous and of the same molecular weight (mol wt approximately 50,200) as native SK. PEG-125I-SK cleared slowly (t1/2 greater than 200 minutes), with more than 80% of the preparation localizing in liver and GI tract. The PEG-125I-SK secreted into the bile was also intact. The bile containing 125I-SK was incubated with stoichiometric amounts of plasminogen and electrophoresed under nondenaturing conditions. This study demonstrated that the secreted SK was able to form SK:Pg complexes. SDS-PAGE also showed activation of 125I-Pg that was incubated with recovered bile containing the SK. 125I-SK:Pm catabolism was also studied. In these experiments, the mol wt approximately 42,000 fragment obtained when SK is cleaved by plasmin was found in the bile. This fragment of 125I-SK was not recovered as part of a complex with plasmin, consistent with our previous observations that catabolism of SK:Pm involves transfer of the plasmin to plasma proteinase inhibitors while SK is catabolized independently. By contrast, when PEG-125I-SK:Pm was injected into mice, only intact PEG-125I-SK was found in the bile, consistent with our previous observations that the PEG derivatization blocks its degradation by plasmin.
Similar articles
-
A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.J Clin Invest. 1985 Feb;75(2):413-9. doi: 10.1172/JCI111715. J Clin Invest. 1985. PMID: 3156148 Free PMC article.
-
Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.J Clin Invest. 1982 Aug;70(2):412-23. doi: 10.1172/jci110631. J Clin Invest. 1982. PMID: 6178757 Free PMC article.
-
Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen.J Biol Chem. 2000 May 12;275(19):14579-89. doi: 10.1074/jbc.275.19.14579. J Biol Chem. 2000. PMID: 10799544
-
The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.Thromb Res. 1989 Apr 15;54(2):133-9. doi: 10.1016/0049-3848(89)90043-1. Thromb Res. 1989. PMID: 2526391
-
[Degradation of streptokinase and the catalytic properties of the plasmin-streptokinase complex].Ukr Biokhim Zh (1999). 2002 May-Jun;74(3):50-7. Ukr Biokhim Zh (1999). 2002. PMID: 12916237 Ukrainian.
Cited by
-
Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.Infect Immun. 2003 Nov;71(11):6199-204. doi: 10.1128/IAI.71.11.6199-6204.2003. Infect Immun. 2003. PMID: 14573637 Free PMC article.
-
Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life.Appl Environ Microbiol. 1998 Mar;64(3):824-9. doi: 10.1128/AEM.64.3.824-829.1998. Appl Environ Microbiol. 1998. PMID: 9501422 Free PMC article.
-
Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.Clin Diagn Lab Immunol. 2002 Nov;9(6):1253-9. doi: 10.1128/cdli.9.6.1253-1259.2002. Clin Diagn Lab Immunol. 2002. PMID: 12414758 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources